National Health Investors, Inc. (NHI) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in National Health Investors, Inc. (NYSE:NHI) by 5.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 14,750 shares of the real estate investment trust’s stock after buying an additional 814 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in National Health Investors were worth $1,071,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Stephens Inc. AR purchased a new stake in National Health Investors during the third quarter valued at about $200,000. Ladenburg Thalmann Financial Services Inc. boosted its stake in National Health Investors by 6.8% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,861 shares of the real estate investment trust’s stock valued at $212,000 after buying an additional 182 shares during the last quarter. Doyle Wealth Management purchased a new stake in National Health Investors during the first quarter valued at about $227,000. Daiwa Securities Group Inc. boosted its stake in National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after buying an additional 55 shares during the last quarter. Finally, New York State Teachers Retirement System boosted its stake in National Health Investors by 3.1% in the fourth quarter. New York State Teachers Retirement System now owns 3,300 shares of the real estate investment trust’s stock valued at $245,000 after buying an additional 100 shares during the last quarter. Institutional investors own 69.06% of the company’s stock.

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

National Health Investors, Inc. (NYSE NHI) opened at 78.05 on Friday. National Health Investors, Inc. has a 1-year low of $66.31 and a 1-year high of $82.53. The stock has a market capitalization of $3.20 billion, a price-to-earnings ratio of 18.95 and a beta of 0.60. The firm has a 50-day moving average of $75.39 and a 200-day moving average of $73.87.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, May 9th. The real estate investment trust reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.26 by $0.16. The firm had revenue of $66.39 million during the quarter, compared to analysts’ expectations of $65.42 million. National Health Investors had a return on equity of 13.36% and a net margin of 63.72%. The business’s revenue was up 12.5% on a year-over-year basis. During the same period last year, the business earned $1.16 earnings per share. Equities research analysts anticipate that National Health Investors, Inc. will post $3.73 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 10th. Stockholders of record on Friday, June 30th will be given a $0.95 dividend. This represents a $3.80 annualized dividend and a dividend yield of 4.87%. The ex-dividend date of this dividend is Wednesday, June 28th. National Health Investors’s dividend payout ratio (DPR) is currently 92.23%.

TRADEMARK VIOLATION WARNING: “National Health Investors, Inc. (NHI) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at https://transcriptdaily.com/2017/06/17/zurcher-kantonalbank-zurich-cantonalbank-purchases-814-shares-of-national-health-investors-inc-nhi-updated-updated.html.

Several equities research analysts recently issued reports on the company. ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday. Cantor Fitzgerald reissued a “neutral” rating and issued a $75.00 target price on shares of National Health Investors in a research note on Tuesday, February 21st. Zacks Investment Research lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Finally, Bank of America Corporation lowered shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 target price on the stock. in a research note on Monday, May 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $78.60.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply